全文获取类型
收费全文 | 3680350篇 |
免费 | 301153篇 |
国内免费 | 15595篇 |
专业分类
耳鼻咽喉 | 51335篇 |
儿科学 | 112222篇 |
妇产科学 | 94834篇 |
基础医学 | 565087篇 |
口腔科学 | 100437篇 |
临床医学 | 333681篇 |
内科学 | 659044篇 |
皮肤病学 | 98928篇 |
神经病学 | 317379篇 |
特种医学 | 146426篇 |
外国民族医学 | 466篇 |
外科学 | 579464篇 |
综合类 | 108994篇 |
现状与发展 | 93篇 |
一般理论 | 2389篇 |
预防医学 | 296841篇 |
眼科学 | 84876篇 |
药学 | 253434篇 |
23篇 | |
中国医学 | 10600篇 |
肿瘤学 | 180545篇 |
出版年
2021年 | 57305篇 |
2020年 | 38159篇 |
2019年 | 59895篇 |
2018年 | 75812篇 |
2017年 | 58637篇 |
2016年 | 64984篇 |
2015年 | 78676篇 |
2014年 | 115943篇 |
2013年 | 181760篇 |
2012年 | 104935篇 |
2011年 | 105589篇 |
2010年 | 123984篇 |
2009年 | 129606篇 |
2008年 | 92068篇 |
2007年 | 96095篇 |
2006年 | 106858篇 |
2005年 | 101219篇 |
2004年 | 102293篇 |
2003年 | 92506篇 |
2002年 | 82461篇 |
2001年 | 111162篇 |
2000年 | 103775篇 |
1999年 | 102842篇 |
1998年 | 67300篇 |
1997年 | 64783篇 |
1996年 | 61849篇 |
1995年 | 57191篇 |
1994年 | 51137篇 |
1993年 | 47651篇 |
1992年 | 72277篇 |
1991年 | 68657篇 |
1990年 | 65479篇 |
1989年 | 64863篇 |
1988年 | 60640篇 |
1987年 | 59251篇 |
1986年 | 56736篇 |
1985年 | 56320篇 |
1984年 | 50764篇 |
1983年 | 46005篇 |
1982年 | 42558篇 |
1981年 | 39982篇 |
1980年 | 37806篇 |
1979年 | 43079篇 |
1978年 | 37496篇 |
1977年 | 34394篇 |
1976年 | 31156篇 |
1975年 | 30779篇 |
1974年 | 32502篇 |
1973年 | 31171篇 |
1972年 | 29579篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
Release of cholecystokinin from rat cerebral cortex in vivo: role of GABA and glutamate receptor systems 总被引:1,自引:0,他引:1
Using cortical cups in chloralose-urethanized rats, the in vivo release of cholecystokinin-like immunoreactivity (CCK-LI) from cerebral cortex was examined. Resting levels of cholecystokinin-like immunoreactivity ranged from 20 to 30 pg/20 min sample. The addition of potassium (40 mM) in excess, resulted in a highly significant elevation in the levels of CCK-LI in the cortical superfusate. Deletion of calcium and the substitution of cobalt (10 mM), resulted in a significant reduction in both resting release and the release otherwise evoked by the addition of potassium. Focal electrical stimulation of the cortex (20 Hz), resulted in a significant (1.9 +/- 0.2-fold, n = 8) increase in the levels of CCK-LI. The addition of glutamate (10(-6)-10(-4) M) of kainic acid (10(-8)-10(-6) M), also resulted in significant elevations in the levels of CCK-LI. The co-administration of a putative glutamate receptor antagonist, kynurenic acid (10(-4) M) resulted in a significant reduction in the levels of release otherwise evoked by the addition of glutamate, but not by electrical stimulation. The addition of GABA (10(-5)-10(-3) M) resulted in a dose-dependent decrease in the resting release of CCK-LI, and the release evoked by glutamate. Picrotoxin (10(-6)-10(-4) M), resulted in a highly significant increase in the levels of CCK-LI in the cortical effluent. These results are consistent with a tonic GABAergic inhibition of CCK-releasing neurons. The treatment of the animal with diazepam (30 mg/kg, i.p.) also resulted in a significant reduction in resting release and the release otherwise evoked by focal cortical stimulation. 相似文献
992.
F Elferink W J van der Vijgh W W ten Bokkel Huinink J B Vermorken I Klein B Winograd M K Knobf G Simonetti H E Gall J G McVie 《British journal of cancer》1987,56(4):479-483
Pharmacokinetics of the cis-platin analog ethylenediaminemalonatoplatinum(II) (JM-410) was studied in 28 cycles of 19 patients during the phase I study of this drug. The drug was administered intravenously by short-term (10-60 min) infusion. Doses ranged from 20 to 1,200mg m-2. JM-40 was determined in plasma ultrafiltrate and urine by HPLC. Platinum (Pt) concentrations were determined in plasma, plasma ultrafiltrate, urine and red blood cells by atomic absorption spectrometry up to 5 days after administration of the drug. Ultrafilterable Pt could be determined up to 45 days after the infusion in one patient sampled over such a long period. Pharmacokinetics of JM-40 showed a linear behaviour. The final half-life of total Pt in plasma was 4.1 +/- 0.9 days. The disposition of JM-40 was similar to that of ultrafilterable Pt in respect to t1/2 alpha (10 and 13 min), t1/2 beta (44 and 57 min), volumes of distribution Vc (11 and 121) and Vss (17 and 201), systemic clearance (256 and 223 ml min-1), renal clearance (69 and 73 ml min-1) and metabolic clearance (183 and 154 ml min-1). During the first 6 h 27 +/- 9% of the administered dose was excreted as JM-40. Cumulative platinum excretion in the urine amounted to 29 +/- 13% and 60 +/- 13% over the first 6 h, 24 h and 5 days, respectively. The uptake of platinum in red blood cells was limited, comprising only 0.24 +/- 0.12% of the administered dose. Although JM-40 and carboplatin are structurally closely related, pharmocokinetics and toxicity of JM-40 were more similar to cis-platin than to carboplatin. 相似文献
993.
Inborn errors of the urea cycle are an important cause of hyperammonaemia throughout childhood, and are associated with high morbidity and mortality rates. If they are diagnosed early and treated appropriately, the outcome for affected children is significantly improved. 相似文献
994.
C.T. PEASE M. FENNELL R.C.D. STAUGHTON D.A. BREWERTON 《The British journal of dermatology》1987,117(2):161-167
Polymorphonuclear leukocyte (PMN) migration was assessed in vitro using the agarose plate method in patients with psoriasis vulgaris, and compared with an age- and sex-matched control group. No significant difference was found between the two groups in the PMN response to the chemotactic substances F-Met-Leu-Phe (FMLP) or zymosan activated serum (ZAS). Equally, the chemokinetic or chemotactic potential of psoriatic serum did not differ from control serum. Our results do not support a primary abnormality of PMN function in psoriasis. 相似文献
995.
996.
997.
998.
999.
The role of Bence Jones proteins (BJPs) in the genesis of the renal dysfunction that develops in patients with multiple myeloma is not clearly defined. We previously evaluated renal function and morphology in a unique strain of rats (LOU/m) bearing tumors which synthesized BJPs with isoelectric points of 5.2, 4.3 and 6.7. Myeloma cast nephropathy developed in one tumor bearing group (pI 5.2), tubular necrosis was observed in another (pI 4.3), and renal function and histology remained normal in a third group (pI 6.7). To see if these renal outcomes were a function of the BJP being excreted or other factors which could be present in the tumor bearing animals, we have examined the effect of chronic intravenous administration of these three BJPs on renal function and histology in non-tumor-bearing LOU/m rats. Urine containing the BJP was collected from tumor bearing rats, sterilized by passage through a 0.2 mu millipore filter, concentrated to 50 mg/ml, and dialyzed extensively so as to remove material with a molecular weight less than 3500. Chronic indwelling-venous catheters were placed in non-tumor-bearing LOU/m rats and these rats were given 100 mg/day for five days of one of the three BJPs. Polyfructosan clearance (Cin) was measured prior to and following the five days of BJP administration. Renal histology was examined at the completion of the second Cin. In the pI 5.2 group (N = 6), a severe distal nephron cast nephropathy occurred and Cin fell from 2.88 +/- 0.24 to 0.90 +/- 0.17 ml/min (P less than 0.002).(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
1000.